Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2022
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast CancerClinton Yam, Nour Abuhadra, Ryan Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2017
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083George Somlo, Paul H Frankel, Banu K Arun, et al.
The Breast Journal|January 15, 2009
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Breast Cancer Risk Reduction, Version 2.2015Therese B Bevers, John H Ward, Banu K Arun, et al.
Cancer Research Communications|October 2, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II StudyClinton Yam, Miral Patel, Holly A Hill, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Ecancermedicalscience|March 25, 2026
The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detectionCharles M Balch, Ning Liao, Dennis S C Lam, et al.
Science (New York, N.Y.)|June 30, 2012
The Paleozoic origin of enzymatic lignin decomposition reconstructed from 31 fungal genomesDimitrios Floudas, Manfred Binder, Robert Riley, et al.
NPJ Breast Cancer|May 12, 2023
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variantsTaru A Muranen, Anna Morra, Sofia Khan, et al.
Pageof 23